206 related articles for article (PubMed ID: 25644759)
1. Neurotensin promotes the progression of malignant glioma through NTSR1 and impacts the prognosis of glioma patients.
Ouyang Q; Gong X; Xiao H; Zhou J; Xu M; Dai Y; Xu L; Feng H; Cui H; Yi L
Mol Cancer; 2015 Feb; 14():21. PubMed ID: 25644759
[TBL] [Abstract][Full Text] [Related]
2. Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.
Dupouy S; Doan VK; Wu Z; Mourra N; Liu J; De Wever O; Llorca FP; Cayre A; Kouchkar A; Gompel A; Forgez P
Oncotarget; 2014 Sep; 5(18):8235-51. PubMed ID: 25249538
[TBL] [Abstract][Full Text] [Related]
3. Neurotensin expression and outcome of malignant pleural mesothelioma.
Alifano M; Loi M; Camilleri-Broet S; Dupouy S; Régnard JF; Forgez P
Biochimie; 2010 Feb; 92(2):164-70. PubMed ID: 19932148
[TBL] [Abstract][Full Text] [Related]
4. Neurotensin receptor1 antagonist SR48692 reduces proliferation by inducing apoptosis and cell cycle arrest in melanoma cells.
Zhang Y; Zhu S; Yi L; Liu Y; Cui H
Mol Cell Biochem; 2014 Apr; 389(1-2):1-8. PubMed ID: 24357116
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin receptor 1 signaling promotes pancreatic cancer progression.
Takahashi K; Ehata S; Miyauchi K; Morishita Y; Miyazawa K; Miyazono K
Mol Oncol; 2021 Jan; 15(1):151-166. PubMed ID: 33034134
[TBL] [Abstract][Full Text] [Related]
6. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
[TBL] [Abstract][Full Text] [Related]
7. Neurotensin (NTS) and its receptor (NTSR1) causes EGFR, HER2 and HER3 over-expression and their autocrine/paracrine activation in lung tumors, confirming responsiveness to erlotinib.
Younes M; Wu Z; Dupouy S; Lupo AM; Mourra N; Takahashi T; Fléjou JF; Trédaniel J; Régnard JF; Damotte D; Alifano M; Forgez P
Oncotarget; 2014 Sep; 5(18):8252-69. PubMed ID: 25249545
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin receptor 1 is a new therapeutic target for human undifferentiated pleomorphic sarcoma growth.
Tokumoto H; Setoguchi T; Saitoh Y; Sasaki H; Nagano S; Maeda S; Tanimoto A; Taniguchi N
Mol Carcinog; 2019 Dec; 58(12):2230-2240. PubMed ID: 31478563
[TBL] [Abstract][Full Text] [Related]
9. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.
Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N
Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521
[TBL] [Abstract][Full Text] [Related]
10. SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner.
Moody TW; Chan DC; Mantey SA; Moreno P; Jensen RT
Life Sci; 2014 Mar; 100(1):25-34. PubMed ID: 24496038
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of neurotensin receptor 1 induces intrinsic apoptosis via let-7a-3p/Bcl-w axis in glioblastoma.
Dong Z; Lei Q; Yang R; Zhu S; Ke XX; Yang L; Cui H; Yi L
Br J Cancer; 2017 Jun; 116(12):1572-1584. PubMed ID: 28494471
[TBL] [Abstract][Full Text] [Related]
12. Diverse expression patterns and tumorigenic role of neurotensin signaling components in colorectal cancer cells.
Kim JT; Weiss HL; Evers BM
Int J Oncol; 2017 Jun; 50(6):2200-2206. PubMed ID: 28498396
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors.
Kamimae S; Yamamoto E; Kai M; Niinuma T; Yamano HO; Nojima M; Yoshikawa K; Kimura T; Takagi R; Harada E; Harada T; Maruyama R; Sasaki Y; Tokino T; Shinomura Y; Sugai T; Imai K; Suzuki H
Oncotarget; 2015 Oct; 6(30):29975-90. PubMed ID: 26334593
[TBL] [Abstract][Full Text] [Related]
14. Differential expression and tumorigenic function of neurotensin receptor 1 in neuroendocrine tumor cells.
Kim JT; Li J; Song J; Lee EY; Weiss HL; Townsend CM; Evers BM
Oncotarget; 2015 Sep; 6(29):26960-70. PubMed ID: 26298774
[TBL] [Abstract][Full Text] [Related]
15. The potential of neurotensin secreted from neuroendocrine tumor cells to promote gelsolin-mediated invasiveness of prostate adenocarcinoma cells.
Hashimoto K; Kyoda Y; Tanaka T; Maeda T; Kobayashi K; Uchida K; Kitamura H; Hirata K; Tsukamoto T; Masumori N
Lab Invest; 2015 Mar; 95(3):283-95. PubMed ID: 25581609
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin Receptor 1 Antagonist SR48692 Improves Response to Carboplatin by Enhancing Apoptosis and Inhibiting Drug Efflux in Ovarian Cancer.
Liu J; Agopiantz M; Poupon J; Wu Z; Just PA; Borghese B; Ségal-Bendirdjian E; Gauchotte G; Gompel A; Forgez P
Clin Cancer Res; 2017 Nov; 23(21):6516-6528. PubMed ID: 28790113
[No Abstract] [Full Text] [Related]
17. Neurotensin and neurotensin receptor 1 expression in human myometrium and uterine leiomyomas.
Rodríguez Y; Almeida TA; Valladares F; Báez D; Montes de Oca F; García C; Dorta I; Hernández M; Reyes R; Bello AR
Biol Reprod; 2010 Oct; 83(4):641-7. PubMed ID: 20592307
[TBL] [Abstract][Full Text] [Related]
18. Adding of neurotensin to non-small cell lung cancer cells increases tyrosine phosphorylation of HER3.
Moody TW; Ramos-Alvarez I; Jensen RT
Peptides; 2022 Oct; 156():170858. PubMed ID: 35932909
[TBL] [Abstract][Full Text] [Related]
19. A Novel Positive Feedback Loop Between NTSR1 and Wnt/β-Catenin Contributes to Tumor Growth of Glioblastoma.
Xiao H; Zeng Y; Wang Q; Wei S; Zhu X
Cell Physiol Biochem; 2017; 43(5):2133-2142. PubMed ID: 29065410
[TBL] [Abstract][Full Text] [Related]
20. The Internalization of Neurotensin by the Low-Affinity Neurotensin Receptors (NTSR2 and vNTSR2) Activates ERK 1/2 in Glioma Cells and Allows Neurotensin-Polyplex Transfection of tGAS1.
Ayala-Sarmiento AE; Martinez-Fong D; Segovia J
Cell Mol Neurobiol; 2015 Aug; 35(6):785-95. PubMed ID: 25772140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]